Study to Evaluate the Safety and Efficacy of ABT-712 in Subjects With Moderate to Severe Chronic Low Back Pain (CLBP)

Completed · Phase 3 · Has a placebo group

Conditions studied: Chronic Low Back Pain

In brief

The primary purpose of the study was to test the efficacy of 2 tablets (twice daily) of ABT-712, compared to placebo, administered over a 4-week period in participants with moderate to severe mechanical chronic low back pain (CLBP).

Key facts

Study ID

NCT00761150

Run by

AbbVie (prior sponsor, Abbott)

People needed

308

Starts

2008-09-01

Expected to finish

2009-03-01

Last updated by the study team

2014-02-07

Who can join

Age: 21 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adult male and female subjects who voluntarily sign the informed consent
• Diagnosis of CLBP of 6 months duration

You may not qualify if…

• Incapacitated or bedridden subjects
• Subjects with history of surgical or invasive intervention

Where it is running

• Site Reference ID/Investigator# 10143 — Tempe, Arizona, United States
• Site Reference ID/Investigator# 10161 — Tempe, Arizona, United States
• Site Reference ID/Investigator# 10155 — Tucson, Arizona, United States
• Site Reference ID/Investigator# 10160 — Anaheim, California, United States
• Site Reference ID/Investigator# 10821 — Lomita, California, United States
• Site Reference ID/Investigator# 10152 — Clearwater, Florida, United States
• Site Reference ID/Investigator# 10157 — DeLand, Florida, United States
• Site Reference ID/Investigator# 10142 — Oldsmar, Florida, United States
• Site Reference ID/Investigator# 10147 — Pembroke Pines, Florida, United States
• Site Reference ID/Investigator# 13821 — Plantation, Florida, United States
• Site Reference ID/Investigator# 15821 — Chicago, Illinois, United States
• Site Reference ID/Investigator# 10136 — Crestview Hills, Kentucky, United States
• Site Reference ID/Investigator# 10822 — New Orleans, Louisiana, United States
• Site Reference ID/Investigator# 10140 — Shreveport, Louisiana, United States
• Site Reference ID/Investigator# 10158 — Brockton, Massachusetts, United States
• Site Reference ID/Investigator# 13601 — Fall River, Massachusetts, United States
• Site Reference ID/Investigator# 10162 — Wellesley Hills, Massachusetts, United States
• Site Reference ID/Investigator# 10159 — Omaha, Nebraska, United States
• Site Reference ID/Investigator# 10126 — Las Vegas, Nevada, United States
• Site Reference ID/Investigator# 10156 — Cincinnati, Ohio, United States
• Site Reference ID/Investigator# 10148 — Cincinnati, Ohio, United States
• Site Reference ID/Investigator# 10151 — Kettering, Ohio, United States
• Site Reference ID/Investigator# 10138 — Marion, Ohio, United States
• Site Reference ID/Investigator# 10150 — Perrysburg, Ohio, United States
• Site Reference ID/Investigator# 10141 — Dallas, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.